ARFIN vs SUNPHARMA: Stock Comparison
Head-to-head financial and trading comparison between Arfin India Limited (ARFIN) and Sun Pharmaceutical Industries Limited (SUNPHARMA) in the Cross-Sector Peers sector.
ARFIN
NSE: ARFINSUNPHARMA
NSE: SUNPHARMAKey Metrics Comparison Table
| Metric | ARFIN | SUNPHARMA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹105.14 | ₹1,760.00 | — |
| 1-Year Price Return | +9.04% | +5.48% | ARFIN (3.56% higher) |
| 52-Week High | ₹107.52 | ₹2,001.10 | — |
| 52-Week Low | ₹82.06 | ₹1,620.40 | — |
| 30-Day Annualized Volatility | 57.5% | 20.49% | SUNPHARMA (Steadier) |
| 30-Day Average Daily Volume | 2,823,186 | 1,603,895 | ARFIN (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between ARFIN and SUNPHARMA, which stock gave better returns over the last year?
ARFIN has outperformed SUNPHARMA over the past 12 months with a gain of 9.04% compared to 5.48%.
Which stock is less volatile: ARFIN or SUNPHARMA?
SUNPHARMA demonstrated lower price volatility (20.49% annualized) compared to ARFIN (57.5%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of ARFIN vs SUNPHARMA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are ARFIN and SUNPHARMA direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.